Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel (European Journal of Clinical Pharmacology, (2018), 74, 4, (443-451), 10.1007/s00228-017-2401-5)

Novkovic, Mirjana (57191976429)Mirjana (57191976429)NovkovicMatic, Dragan (25959220100)Dragan (25959220100)MaticKusic-Tisma, Jelena (6506936932)Jelena (6506936932)Kusic-TismaAntonijevic, Nebojsa (6602303948)Nebojsa (6602303948)AntonijevicRadojkovic, Dragica (6602844151)Dragica (6602844151)RadojkovicRakicevic, Ljiljana (14047140100)Ljiljana (14047140100)Rakicevic2025-06-122025-06-122018https://doi.org/10.1007/s00228-018-2425-5https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044190548&doi=10.1007%2fs00228-018-2425-5&partnerID=40&md5=9ec1c7de9178a310072bef25bf542b45https://remedy.med.bg.ac.rs/handle/123456789/6406The correct Author names are shown in this paper. The original article was corrected. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature.Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel (European Journal of Clinical Pharmacology, (2018), 74, 4, (443-451), 10.1007/s00228-017-2401-5)